-+ 0.00%
-+ 0.00%
-+ 0.00%

ADAGENE ACHIEVES MILESTONE IN COLLABORATION WITH EXELIXIS FOR ADVANCEMENT OF SAFEBODY® ANTIBODY-DRUG CONJUGATE CANDIDATES

Reuters·09/09/2026 12:00:05

Please log in to view news